# H3.3K122A results in a neomorphic phenotype in mouse embryonic stem cells

## TL;DR

A mutation in the H3.3 histone variant leads to a new harmful effect in mouse embryonic stem cells, causing lethality.

## Contribution

The study reveals a neomorphic, lethal phenotype caused by H3.3K122A mutation in mES cells.

## Key findings

- H3.3K122A mutation is neomorphic and causes lethality in mouse embryonic stem cells.
- H3.3-null mES cells are viable but have reduced differentiation capacity.
- The globular domain residue H3.3K122 is crucial for viability and transcription regulation.

## Abstract

The histone variant H3.3 acts in coordination with histone posttranslational modifications and other chromatin features to facilitate appropriate transcription. Canonical histone H3 and histone variant H3.3 are post-translationally modified with the genomic distribution of these marks denoting different features and with more recent evidence suggesting that these modifications may influence transcription. While the majority of posttranslational modifications occur on histone tails, there are defined modifications within the globular domain, such as acetylation of H3K122/H3.3K122. To understand the function of the residue H3.3K122 in transcriptional regulation, we attempted to generate H3.3K122A mouse embryonic stem (mES) cells but were unsuccessful. Through multi-omic profiling of mutant cell lines harboring two or three of four H3.3 targeted alleles, we have uncovered that H3.3K122A is neomorphic and results in lethality. This is surprising as prior studies demonstrate H3.3-null mES cells are viable and pluripotent, albeit with reduced differentiation capacity. Together, these studies have uncovered a novel dependence of a globular domain residue of H3.3 for viability and broadened our understanding of how histone variants contribute to transcription regulation and pluripotency in mES cells.